Management of Intracerebral Hemorrhage: JACC Focus Seminar.
| Autor: | Schrag M; Vanderbilt University School of Medicine, Department of Neurology, Nashville, Tennessee. Electronic address: matthew.schrag@vanderbilt.edu., Kirshner H; Vanderbilt University School of Medicine, Department of Neurology, Nashville, Tennessee. Electronic address: howard.kirshner@vumc.org. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of the American College of Cardiology [J Am Coll Cardiol] 2020 Apr 21; Vol. 75 (15), pp. 1819-1831. |
| DOI: | 10.1016/j.jacc.2019.10.066 |
| Abstrakt: | Intracerebral hemorrhage (ICH) accounts for a disproportionate amount of stroke-related morbidity and mortality. Although chronic hypertension and cerebral amyloid angiopathy are the underlying cerebral vasculopathies accounting for the majority of ICH, there are a broad range of potential causes, and effective management requires accurate identification and treatment of the underlying mechanism of hemorrhage. Magnetic resonance imaging and vascular imaging techniques play a critical role in identifying disease mechanisms. Modern treatment of ICH focuses on rapid stabilization, often requiring urgent treatment of mass effect, aggressive blood pressure reduction and correction of contributing coagulopathies to achieve hemostasis. We discuss management of patients with ICH who continue to require long-term anticoagulation, the interaction of ICH with neurodegenerative diseases, and our approach to prognostication after ICH. We close this review with a discussion of novel medical and surgical approaches to ICH treatment that are being tested in clinical trials. (Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|